Skip to main content
COVID-19
15/10/2021 - 14:00

Dimerix starts COVID-19 drug trials

15/10/2021 - 14:00
COVID-19

Bookmark

Save articles for future reference.

Perth-founded biopharmaceutical business Dimerix has launched phase three drug trials for patients with COVID-19 and kidney diseases.

X

To read our articles you will need to either login or subscribe.